Our results demonstrated that the CXCL14/CCR7/STAT3 axis significantly promotes the glycolytic shift in bladder cancer cells by upregulating the expression of HK2 and LDHA, two key glycolytic enzymes. This evidence concerns the gene LDHA and urinary bladder cancer.